Replies to post #254346 on Avid Bioservices Inc (CDMO)

[chevalblanc-47]

thanks Tradero, I go for astronomical MOS :-)
Maybe the DMC meeting took place but I don't believe Peregrine management has any info about it.
Volume is way too low. In the last 20 years volume always picked up dramatically before big news.Leaky as a sieve.
But we are only weeks/months away fom the final verdict about Bavi.

kind regards
danny

PS RIP rrdog/Jeff, I keep reading his last message, great guy.

[north40000]

Tradero , I must have missed something. Can you educate me with a link that supports your statement[a hypothetical to me, so far] that Sunrise hospitals were actually asked to send their Sunrise data to IDMC on or about January 31, 2016? or the beginning of 2016?

[Protector]

SUNRISE PR

This sounds like 1st ln NSCLC - Control arm DRASTICALLY outperforming historical studies!!! AGAIN.

The interim analysis showed that the bavituximab combination group is performing as expected according to the original trial assumptions in terms of overall survival, while the docetaxel group is dramatically outperforming overall survival expectations based on the original trial assumptions and as compared to recently published studies.